Tirasemtiv Terminated Phase 2 Trials for Myasthenia Gravis Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01268280Pharmacodynamic Study of CK-2017357 in Patients With Generalized Myasthenia Gravis